The genetic architecture of rheumatoid arthritis: From susceptibility to clinical subphenotype associations

Current Topics in Medicinal Chemistry

Volumn 13, Issue 6, 2013, Pages 720-731

  Julià, Antonio ^a   Marsal, Sara ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

ACPA; Disease severity; Genetics; GWAS; HLA; Pharmacogenetics; Rheumatoid arthritis; Risk

Indexed keywords

CD20 ANTIGEN; CD45 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; HLA DRB1 ANTIGEN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 6; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ARTICLE; CHROMOSOME 6; DISEASE SEVERITY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PERSONALIZED MEDICINE; PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84878805368     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313060005     Document Type: Article

References (99)

1. Lawrence, J. S., Heberden Oration, 1969. Rheumatoid arthritis-nature or nurture? Ann Rheum Dis 1970, 29, (4), 357-79.
2. Arnett, F. C.; Edworthy, S. M.; Bloch, D. A.; McShane, D. J.; Fries, J. F.; Cooper, N. S.; Healey, L. A.; Kaplan, S. R.; Liang, M. H.; Luthra, H. S., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 1988, 31, (3), 315-24.
3. Watson, J. D.; Crick, F. H., Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953, 171, (4356), 737-8.
4. Crick, F., Central dogma of molecular biology. Nature 1970, 227, (5258), 561-3.
5. DeLisi, C., Meetings that changed the world: Santa Fe 1986: Human genome baby-steps. Nature 2008, 455, (7215), 876-7.
6. Aho, K.; Koskenvuo, M.; Tuominen, J.; Kaprio, J., Occurrence of rheumatoid arthritis in a nationwide series of twins. The Journal of Rheumatology 1986, 13, (5), 899-902.
7. Silman, A. J.; MacGregor, A. J.; Thomson, W.; Holligan, S.; Carthy, D.; Farhan, A.; Ollier, W. E., Twin concordance rates for rheumatoid arthritis: results from a nationwide study. British Journal of Rheumatology 1993, 32, (10), 903-7.
8. MacGregor, A. J.; Snieder, H.; Rigby, A. S.; Koskenvuo, M.; Kaprio, J.; Aho, K.; Silman, A. J., Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis and Rheumatism 2000, 43, (1), 30-7.
9. Horton, R.; Wilming, L.; Rand, V.; Lovering, R. C.; Bruford, E. A.; Khodiyar, V. K.; Lush, M. J.; Povey, S.; Talbot, C. C., Jr.; Wright, M. W.; Wain, H. M.; Trowsdale, J.; Ziegler, A.; Beck, S., Gene map of the extended human MHC. Nat Rev Genet 2004, 5, (12), 889-99.
10. Campbell, R. D.; Trowsdale, J., Map of the human MHC. Immunol Today 1993, 14, (7), 349-52.
11. Dupont, B.; Good, R. A.; Hansen, G. S.; Jersild, C.; Nielsen, L. S.; Park, B. H.; Svejgaard, A.; Thomsen, M.; Yunis, E. J., Two separate genes controlling stimulation in mixed lymphocyte reaction in man. Proc Natl Acad Sci U S A 1974, 71, (1), 52-6.
12. Stastny, P., Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976, 57, (5), 1148-57.
13. Gregersen, P. K.; Silver, J.; Winchester, R. J., The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987, 30, (11), 1205-13.
14. Rose, N. R.; Bona, C., Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993, 14, (9), 426-30.
15. Rose, N. R.; Kite, J. H., Jr.; Doebbler, T. K.; Spier, R.; Skelton, F. R.; Witebsky, E., Studies on experimental thyroiditis. Ann N Y Acad Sci 1965, 124, (1), 201-30.
16. Zinkernagel, R. M.; Doherty, P. C., Restriction of in vitro T cellmediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974, 248, (450), 701-2.
17. Firestein, G. S., Evolving concepts of rheumatoid arthritis. Nature 2003, 423, (6937), 356-61.
18. Klareskog, L.; Catrina, A. I.; Paget, S., Rheumatoid arthritis. Lancet 2009, 373, (9664), 659-72.
19. Lundberg, K.; Nijenhuis, S.; Vossenaar, E. R.; Palmblad, K.; van Venrooij, W. J.; Klareskog, L.; Zendman, A. J.; Harris, H. E., Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005, 7, (3), R458-67.
20. Lu, M. C.; Lai, N. S.; Yu, H. C.; Huang, H. B.; Hsieh, S. C.; Yu, C. L., Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis Rheum 2010, 62, (5), 1213-23.
21. Klareskog, L.; Stolt, P.; Lundberg, K.; Kallberg, H.; Bengtsson, C.; Grunewald, J.; Ronnelid, J.; Harris, H. E.; Ulfgren, A. K.; Rantapaa-Dahlqvist, S.; Eklund, A.; Padyukov, L.; Alfredsson, L., A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54, (1), 38-46.
22. Lundberg, K.; Bengtsson, C.; Kharlamova, N.; Reed, E.; Jiang, X.; Kallberg, H.; Pollak-Dorocic, I.; Israelsson, L.; Kessel, C.; Padyukov, L.; Holmdahl, R.; Alfredsson, L.; Klareskog, L., Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis 2012.
23. Viatte, S.; Plant, D.; Bowes, J.; Lunt, M.; Eyre, S.; Barton, A.; Worthington, J., Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann Rheum Dis 2011, 71, (12), 1984-90.
24. van der Woude, D.; Houwing-Duistermaat, J. J.; Toes, R. E.; Huizinga, T. W.; Thomson, W.; Worthington, J.; van der Helm-van Mil, A. H.; de Vries, R. R., Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibodynegative rheumatoid arthritis. Arthritis Rheum 2009, 60, (4), 916-23.
25. Risch, N., Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990, 46, (2), 222-8.
26. Shiozawa, S.; Hayashi, S.; Tsukamoto, Y.; Goko, H.; Kawasaki, H.; Wada, T.; Shimizu, K.; Yasuda, N.; Kamatani, N.; Takasugi, K.; Tanaka, Y.; Shiozawa, K.; Imura, S., Identification of the gene loci that predispose to rheumatoid arthritis. International Immunology 1998, 10, (12), 1891-5.
27. Jawaheer, D.; Seldin, M.; Amos, C.; Chen, W.; Shigeta, R.; Monteiro, J.; Kern, M.; Criswell, L.; Albani, S.; Nelson, J.; Clegg, D.; Pope, R.; Schroeder, H. J.; Bridges, S. J.; Pisetsky, D.; Ward, R.; Kastner, D.; Wilder, R.; Pincus, T.; Callahan, L.; Flemming, D.; Wener, M.; Gregersen, P., A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. American Journal of Human Genetics 2001, 68, (4), 927-36.
28. MacKay, K.; Eyre, S.; Myerscough, A.; Milicic, A.; Barton, A.; Laval, S.; Barrett, J.; Lee, D.; White, S.; John, S.; Brown, M. A.; Bell, J.; Silman, A.; Ollier, W.; Wordsworth, P.; Worthington, J., Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis and Rheumatism 2002, 46, (3), 632-9.
29. Hirschhorn, J. N.; Altshuler, D., Once and again-issues surrounding replication in genetic association studies. J Clin Endocrinol Metab 2002, 87, (10), 4438-41.
30. Suzuki, A.; Yamada, R.; Chang, X.; Tokuhiro, S.; Sawada, T.; Suzuki, M.; Nagasaki, M.; Nakayama-Hamada, M.; Kawaida, R.; Ono, M.; Ohtsuki, M.; Furukawa, H.; Yoshino, S.; Yukioka, M.; Tohma, S.; Matsubara, T.; Wakitani, S.; Teshima, R.; Nishioka, Y.; Sekine, A.; Iida, A.; Takahashi, A.; Tsunoda, T.; Nakamura, Y.; Yamamoto, K., Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34, (4), 395-402.
31. Cornelis, F.; Faure, S.; Martinez, M.; Prud'homme, J. F.; Fritz, P.; Dib, C.; Alves, H.; Barrera, P.; de Vries, N.; Balsa, A.; PascualSalcedo, D.; Maenaut, K.; Westhovens, R.; Migliorini, P.; Tran, T. H.; Delaye, A.; Prince, N.; Lefevre, C.; Thomas, G.; Poirier, M.; Soubigou, S.; Alibert, O.; Lasbleiz, S.; Fouix, S.; Weissenbach J.; et al., New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 1998, 95, (18), 10746-50.
32. Freudenberg, J.; Lee, H. S.; Han, B. G.; Shin, H. D.; Kang, Y. M.; Sung, Y. K.; Shim, S. C.; Choi, C. B.; Lee, A. T.; Gregersen, P. K.; Bae, S. C., Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci. Arthritis Rheum 2011, 63, (4), 884-93.
33. Eyre, S.; Bowes, J.; Diogo, D.; Lee, A.; Barton, A.; Martin, P.; Zhernakova, A.; Stahl, E.; Viatte, S.; McAllister, K.; Amos, C. I.; Padyukov, L.; Toes, R. E.; Huizinga, T. W.; Wijmenga, C.; Trynka, G.; Franke, L.; Westra, H. J.; Alfredsson, L.; Hu, X.; Sandor, C.; de Bakker, P. I.; Davila, S.; Khor, C. C.; Heng, K. K.; Andrews, R.; Edkins, S.; Hunt, S. E.; Langford, C.; Symmons, D.; Concannon, P.; Onengut-Gumuscu, S.; Rich, S. S.; Deloukas, P.; GonzalezGay, M. A.; Rodriguez-Rodriguez, L.; Arlsetig, L.; Martin, J.; Rantapaa-Dahlqvist, S.; Plenge, R. M.; Raychaudhuri, S.; Klareskog, L.; Gregersen, P. K.; Worthington, J., High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012, 44, (12), 1336-40.
34. Begovich, A. B.; Carlton, V. E.; Honigberg, L. A.; Schrodi, S. J.; Chokkalingam, A. P.; Alexander, H. C.; Ardlie, K. G.; Huang, Q.; Smith, A. M.; Spoerke, J. M.; Conn, M. T.; Chang, M.; Chang, S. Y.; Saiki, R. K.; Catanese, J. J.; Leong, D. U.; Garcia, V. E.; McAllister, L. B.; Jeffery, D. A.; Lee, A. T.; Batliwalla, F.; Remmers, E.; Criswell, L. A.; Seldin, M. F.; Kastner, D. L.; Amos, C. I.; Sninsky, J. J.; Gregersen, P. K., A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75, (2), 330-7.
35. Kallberg, H.; Padyukov, L.; Plenge, R. M.; Ronnelid, J.; Gregersen, P. K.; van der Helm-van Mil, A. H.; Toes, R. E.; Huizinga, T. W.; Klareskog, L.; Alfredsson, L., Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007, 80, (5), 867-75.
36. Hasegawa, K.; Martin, F.; Huang, G.; Tumas, D.; Diehl, L.; Chan, A. C., PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004, 303, (5658), 685-9.
37. Daha, N. A.; Kurreeman, F. A.; Marques, R. B.; Stoeken-Rijsbergen, G.; Verduijn, W.; Huizinga, T. W.; Toes, R. E., Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum 2009, 60, (5), 1255-60.
38. Wing, K.; Onishi, Y.; Prieto-Martin, P.; Yamaguchi, T.; Miyara, M.; Fehervari, Z.; Nomura, T.; Sakaguchi, S., CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322, (5899), 271-5.
39. Kremer, J. M.; Westhovens, R.; Leon, M.; Di Giorgio, E.; Alten, R.; Steinfeld, S.; Russell, A.; Dougados, M.; Emery, P.; Nuamah, I. F.; Williams, G. R.; Becker, J. C.; Hagerty, D. T.; Moreland, L. W., Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003, 349, (20), 1907-15.
40. Ding, B.; Padyukov, L.; Lundstrom, E.; Seielstad, M.; Plenge, R. M.; Oksenberg, J. R.; Gregersen, P. K.; Alfredsson, L.; Klareskog, L., Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 2009, 60, (1), 30-8.
41. Schena, M.; Shalon, D.; Heller, R.; Chai, A.; Brown, P. O.; Davis, R. W., Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 1996, 93, (20), 10614-9.
42. Lipshutz, R. J.; Fodor, S. P.; Gingeras, T. R.; Lockhart, D. J., High density synthetic oligonucleotide arrays. Nat Genet 1999, 21, (1 Suppl), 20-4.
43. The International HapMap Project. Nature 2003, 426, (6968), 789-96.
44. Lander, E. S., The new genomics: global views of biology. Science 1996, 274, (5287), 536-9.
45. Risch, N.; Merikangas, K., The future of genetic studies of complex human diseases. Science 1996, 273, (5281), 1516-7.
46. Kruglyak, L., The road to genome-wide association studies. Nat Rev Genet 2008, 9, (4), 314-8.
47. WTCC, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447, (7145), 661-78.
48. Plenge, R. M.; Seielstad, M.; Padyukov, L.; Lee, A. T.; Remmers, E. F.; Ding, B.; Liew, A.; Khalili, H.; Chandrasekaran, A.; Davies, L. R.; Li, W.; Tan, A. K.; Bonnard, C.; Ong, R. T.; Thalamuthu, A.; Pettersson, S.; Liu, C.; Tian, C.; Chen, W. V.; Carulli, J. P.; Beckman, E. M.; Altshuler, D.; Alfredsson, L.; Criswell, L. A.; Amos, C. I.; Seldin, M. F.; Kastner, D. L.; Klareskog, L.; Gregersen, P. K., TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med 2007, 357, (12), 1199-209.
49. Plenge, R. M.; Cotsapas, C.; Davies, L.; Price, A. L.; de Bakker, P. I.; Maller, J.; Pe'er, I.; Burtt, N. P.; Blumenstiel, B.; Defelice, M.; Parkin, M.; Barry, R.; Winslow, W.; Healy, C.; Graham, R. R.; Neale, B. M.; Izmailova, E.; Roubenoff, R.; Parker, A. N.; Glass, R.; Karlson, E. W.; Maher, N.; Hafler, D. A.; Lee, D. M.; Seldin, M. F.; Remmers, E. F.; Lee, A. T.; Padyukov, L.; Alfredsson, L.; Coblyn, J.; Weinblatt, M. E.; Gabriel, S. B.; Purcell, S.; Klareskog, L.; Gregersen, P. K.; Shadick, N. A.; Daly, M. J.; Altshuler, D., Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007, 4, 4.
50. Thomson, W.; Barton, A.; Ke, X.; Eyre, S.; Hinks, A.; Bowes, J.; Donn, R.; Symmons, D.; Hider, S.; Bruce, I. N.; Wilson, A. G.; Marinou, I.; Morgan, A.; Emery, P.; Carter, A.; Steer, S.; Hocking, L.; Reid, D. M.; Wordsworth, P.; Harrison, P.; Strachan, D.; Worthington, J., Rheumatoid arthritis association at 6q23. Nat Genet 2007, 39, (12), 1431-3.
51. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306, (5696), 636-40.
52. Dunham, I.; Kundaje, A.; Aldred, S. F.; Collins, P. J.; Davis, C. A.; Doyle, F.; Epstein, C. B.; Frietze, S.; Harrow, J.; Kaul, R.; Khatun, J.; Lajoie, B. R.; Landt, S. G.; Lee, B. K.; Pauli, F.; Rosenbloom, K. R.; Sabo, P.; Safi, A.; Sanyal, A.; Shoresh, N.; Simon, J. M.; Song, L.; Trinklein, N. D.; Altshuler, R. C.; Birney, E.; Brown, J. B.; Cheng, C.; Djebali, S.; Dong, X.; Dunham, I.; Ernst, J.; Furey, T. S.; Gerstein, M.; Giardine, B.; Greven, M.; Hardison, R. C.; Harris, R. S.; Herrero, J.; Hoffman, M. M.; Iyer, S.; Kelllis, M.; Khatun, J.; Kheradpour, P.; Kundaje, A.; Lassman, T.; Li, Q.; Lin, X.; Marinov, G. K.; Merkel, A.; Mortazavi, A.; Parker, S. C.; Reddy, T. E.; Rozowsky, J.; Schlesinger, F.; Thurman, R. E.; Wang, J.; Ward, L. D.; Whitfield, T. W.; Wilder, S. P.; Wu, W.; Xi, H. S.; Yip, K. Y.; Zhuang, J.; Bernstein, B. E.; Birney, E.; Dunham, I.; Green, E. D.; Gunter, C.; Snyder, M.; Pazin, M. J.; Lowdon, R. F.; Dillon, L. A.; Adams, L. B.; Kelly, C. J.; Zhang, J.; Wexler, J. R.; Green, E. D.; Good, P. J.; Feingold, E. A.; Bernstein, B. E.; Birney, E.; Crawford, G. E.; Dekker, J.; Elinitski, L.; Farnham, P. J.; Gerstein, M.; Giddings, M. C.; Gingeras, T. R.; Green, E. D.; Guigo, R.; Hardison, R. C.; Hubbard, T. J.; Kellis, M.; Kent, W. J.; Lieb, J. D.; Margulies, E. H.; Myers, R. M.; Snyder, M.; Starnatoyannopoulos, J. A.; Tennebaum, S. A.; Weng, Z.; White, K. P.; Wold, B.; Khatun, J.; Yu, Y.; Wrobel, J.; Risk, B. A.; Gunawardena, H. P.; Kuiper, H. C.; Maier, C. W.; Xie, L.; Chen, X.; Giddings, M. C.; Bernstein, B. E.; Epstein, C. B.; Shoresh, N.; Ernst, J.; Kheradpour, P.; Mikkelsen, T. S.; Gillespie, S.; Goren, A.; Ram, O.; Zhang, X.; Wang, L.; Issner, R.; Coyne, M. J.; Durham, T.; Ku, M.; Truong, T.; Ward, L. D.; Altshuler, R. C.; Eaton, M. L.; Kellis, M.; Djebali, S.; Davis, C. A.; Merkel, A.; Dobin, A.; Lassmann, T.; Mortazavi, A.; Tanzer, A.; Lagarde, J.; Lin, W.; Schlesinger, F.; Xue, C.; Marinov, G. K.; Khatun, J.; Williams, B. A.; Zaleski, C.; Rozowsky, J.; Roder, M.; Kokocinski, F.; Abdelhamid, R. F.; Alioto, T.; Antoshechkin, I.; Baer, M. T.; Batut, P.; Bell, I.; Bell, K.; Chakrabortty, S.; Chen, X.; Chrast, J.; Curado, J.; Derrien, T.; Drenkow, J.; Dumais, E.; Dumais, J.; Duttagupta, R.; Fastuca, M.; Fejes-Toth, K.; Ferreira, P.; Foissac, S.; Fullwood, M. J.; Gao, H.; Gonzalez, D.; Gordon, A.; Gunawardena, H. P.; Howald, C.; Jha, S.; Johnson, R.; Kapranov, P.; King, B.; Kingswood, C.; Li, G.; Luo, O. J.; Park, E.; Preall, J. B.; Presaud, K.; Ribeca, P.; Risk, B. A.; Robyr, D.; Ruan, X.; Sammeth, M.; Sandu, K. S.; Schaeffer, L.; See, L. H.; Shahab, A.; Skancke, J.; Suzuki, A. M.; Takahashi, H.; Tilgner, H.; Trout, D.; Walters, N.; Wang, H.; Wrobel, J.; Yu, Y.; Hayashizaki, Y.; Harrow, J.; Gerstein, M.; Hubbard, T. J.; Reymond, A.; Antonarakis, S. E.; Hannon, G. J.; Giddings, M. C.; Ruan, Y.; Wold, B.; Carninci, P.; Guigo, R.; Gingeras, T. R.; Rosenbloom, K. R.; Sloan, C. A.; Learned, K.; Malladi, V. S.; Wong, M. C.; Barber, G. P.; Cline, M. S.; Dreszer, T. R.; Heitner, S. G.; Karolchik, D.; Kent, W. J.; Kirkup, V. M.; Meyer, L. R.; Long, J. C.; Maddren, M.; Raney, B. J.; Furey, T. S.; Song, L.; Grasfeder, L. L.; Giresi, P. G.; Lee, B. K.; Battenhouse, A.; Sheffield, N. C.; Simon, J. M.; Showers, K. A.; Safi, A.; London, D.; Bhinge, A. A.; Shestak, C.; Schaner, M. R.; Kim, S. K.; Zhang, Z. Z.; Mieczkowski, P. A.; Mieczkowska, J. O.; Liu, Z.; McDaniell, R. M.; Ni, Y.; Rashid, N. U.; Kim, M. J.; Adar, S.; Zhang, Z.; Wang, T.; Winter, D.; Keefe, D.; Birney, E.; Iyer, V. R.; Lieb, J. D.; Crawford, G. E.; Li, G.; Sandhu, K. S.; Zheng, M.; Wang, P.; Luo, O. J.; Shahab, A.; Fullwood, M. J.; Ruan, X.; Ruan, Y.; Myers, R. M.; Pauli, F.; Williams, B. A.; Gertz, J.; Marinov, G. K.; Reddy, T. E.; Vielmetter, J.; Partridge, E. C.; Trout, D.; Varley, K. E.; Gasper, C.; Bansal, A.; Pepke, S.; Jain, P.; Amrhein, H.; Bowling, K. M.; Anaya, M.; Cross, M. K.; King, B.; Muratet, M. A.; Antoshechkin, I.; Newberry, K. M.; McCue, K.; Nesmith, A. S.; Fisher-Aylor, K. I.; Pusey, B.; DeSalvo, G.; Parker, S. L.; Balasubramanian, S.; Davis, N. S.; Meadows, S. K.; Eggleston, T.; Gunter, C.; Newberry, J. S.; Levy, S. E.; Absher, D. M.; Mortazavi, A.; Wong, W. H.; Wold, B.; Blow, M. J.; Visel, A.; Pennachio, L. A.; Elnitski, L.; Margulies, E. H.; Parker, S. C.; Petrykowska, H. M.; Abyzov, A.; Aken, B.; Barrell, D.; Barson, G.; Berry, A.; Bignell, A.; Boychenko, V.; Bussotti, G.; Chrast, J.; Davidson, C.; Derrien, T.; Despacio-Reyes, G.; Diekhans, M.; Ezkurdia, I.; Frankish, A.; Gilbert, J.; Gonzalez, J. M.; Griffiths, E.; Harte, R.; Hendrix, D. A.; Howald, C.; Hunt, T.; Jungreis, I.; Kay, M.; Khurana, E.; Kokocinski, F.; Leng, J.; Lin, M. F.; Loveland, J.; Lu, Z.; Manthravadi, D.; Mariotti, M.; Mudge, J.; Mukherjee, G.; Notredame, C.; Pei, B.; Rodriguez, J. M.; Saunders, G.; Sboner, A.; Searle, S.; Sisu, C.; Snow, C.;, An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, (7414), 57-74.
53. Hirschhorn, J. N., Genomewide association studies--illuminating biologic pathways. N Engl J Med 2009, 360, (17), 1699-701.
54. Stahl, E. A.; Raychaudhuri, S.; Remmers, E. F.; Xie, G.; Eyre, S.; Thomson, B. P.; Li, Y.; Kurreeman, F. A.; Zhernakova, A.; Hinks, A.; Guiducci, C.; Chen, R.; Alfredsson, L.; Amos, C. I.; Ardlie, K. G.; Barton, A.; Bowes, J.; Brouwer, E.; Burtt, N. P.; Catanese, J. J.; Coblyn, J.; Coenen, M. J.; Costenbader, K. H.; Criswell, L. A.; Crusius, J. B.; Cui, J.; de Bakker, P. I.; De Jager, P. L.; Ding, B.; Emery, P.; Flynn, E.; Harrison, P.; Hocking, L. J.; Huizinga, T. W.; Kastner, D. L.; Ke, X.; Lee, A. T.; Liu, X.; Martin, P.; Morgan, A. W.; Padyukov, L.; Posthumus, M. D.; Radstake, T. R.; Reid, D. M.; Seielstad, M.; Seldin, M. F.; Shadick, N. A.; Steer, S.; Tak, P. P.; Thomson, W.; van der Helm-van Mil, A. H.; van der Horst-Bruinsma, I. E.; van der Schoot, C. E.; van Riel, P. L.; Weinblatt, M. E.; Wilson, A. G.; Wolbink, G. J.; Wordsworth, B. P.; Wijmenga, C.; Karlson, E. W.; Toes, R. E.; de Vries, N.; Begovich, A. B.; Worthington, J.; Siminovitch, K. A.; Gregersen, P. K.; Klareskog, L.; Plenge, R. M., Genome-wide association study metaanalysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42, (6), 508-14.
55. Vella, A.; Cooper, J. D.; Lowe, C. E.; Walker, N.; Nutland, S.; Widmer, B.; Jones, R.; Ring, S. M.; McArdle, W.; Pembrey, M. E.; Strachan, D. P.; Dunger, D. B.; Twells, R. C.; Clayton, D. G.; Todd, J. A., Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005, 76, (5), 773-9.
56. Zhernakova, A.; Stahl, E. A.; Trynka, G.; Raychaudhuri, S.; Festen, E. A.; Franke, L.; Westra, H. J.; Fehrmann, R. S.; Kurreeman, F. A.; Thomson, B.; Gupta, N.; Romanos, J.; McManus, R.; Ryan, A. W.; Turner, G.; Brouwer, E.; Posthumus, M. D.; Remmers, E. F.; Tucci, F.; Toes, R.; Grandone, E.; Mazzilli, M. C.; Rybak, A.; Cukrowska, B.; Coenen, M. J.; Radstake, T. R.; van Riel, P. L.; Li, Y.; de Bakker, P. I.; Gregersen, P. K.; Worthington, J.; Siminovitch, K. A.; Klareskog, L.; Huizinga, T. W.; Wijmenga, C.; Plenge, R. M., Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011, 7, (2), e1002004.
57. Canton, I.; Akhtar, S.; Gavalas, N. G.; Gawkrodger, D. J.; Blomhoff, A.; Watson, P. F.; Weetman, A. P.; Kemp, E. H., A singlenucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 2005, 6, (7), 584-7.
58. Sigurdsson, S.; Nordmark, G.; Goring, H. H.; Lindroos, K.; Wiman, A. C.; Sturfelt, G.; Jonsen, A.; Rantapaa-Dahlqvist, S.; Moller, B.; Kere, J.; Koskenmies, S.; Widen, E.; Eloranta, M. L.; Julkunen, H.; Kristjansdottir, H.; Steinsson, K.; Alm, G.; Ronnblom, L.; Syvanen, A. C., Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005, 76, (3), 528-37.
59. De Jager, P. L.; Jia, X.; Wang, J.; de Bakker, P. I.; Ottoboni, L.; Aggarwal, N. T.; Piccio, L.; Raychaudhuri, S.; Tran, D.; Aubin, C.; Briskin, R.; Romano, S.; Baranzini, S. E.; McCauley, J. L.; Pericak-Vance, M. A.; Haines, J. L.; Gibson, R. A.; Naeglin, Y.; Uitdehaag, B.; Matthews, P. M.; Kappos, L.; Polman, C.; McArdle, W. L.; Strachan, D. P.; Evans, D.; Cross, A. H.; Daly, M. J.; Compston, A.; Sawcer, S. J.; Weiner, H. L.; Hauser, S. L.; Hafler, D. A.; Oksenberg, J. R., Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009, 41, (7), 776-82.
60. de Cid, R.; Riveira-Munoz, E.; Zeeuwen, P. L.; Robarge, J.; Liao, W.; Dannhauser, E. N.; Giardina, E.; Stuart, P. E.; Nair, R.; Helms, C.; Escaramis, G.; Ballana, E.; Martin-Ezquerra, G.; den Heijer, M.; Kamsteeg, M.; Joosten, I.; Eichler, E. E.; Lazaro, C.; Pujol, R. M.; Armengol, L.; Abecasis, G.; Elder, J. T.; Novelli, G.; Armour, J. A.; Kwok, P. Y.; Bowcock, A.; Schalkwijk, J.; Estivill, X., Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009, 41, (2), 211-5.
61. Barrett, J. C.; Hansoul, S.; Nicolae, D. L.; Cho, J. H.; Duerr, R. H.; Rioux, J. D.; Brant, S. R.; Silverberg, M. S.; Taylor, K. D.; Barmada, M. M.; Bitton, A.; Dassopoulos, T.; Datta, L. W.; Green, T.; Griffiths, A. M.; Kistner, E. O.; Murtha, M. T.; Regueiro, M. D.; Rotter, J. I.; Schumm, L. P.; Steinhart, A. H.; Targan, S. R.; Xavier, R. J.; Libioulle, C.; Sandor, C.; Lathrop, M.; Belaiche, J.; Dewit, O.; Gut, I.; Heath, S.; Laukens, D.; Mni, M.; Rutgeerts, P.; Van Gossum, A.; Zelenika, D.; Franchimont, D.; Hugot, J. P.; de Vos, M.; Vermeire, S.; Louis, E.; Cardon, L. R.; Anderson, C. A.; Drummond, H.; Nimmo, E.; Ahmad, T.; Prescott, N. J.; Onnie, C. M.; Fisher, S. A.; Marchini, J.; Ghori, J.; Bumpstead, S.; Gwilliam, R.; Tremelling, M.; Deloukas, P.; Mansfield, J.; Jewell, D.; Satsangi, J.; Mathew, C. G.; Parkes, M.; Georges, M.; Daly, M. J., Genomewide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40, (8), 955-62.
62. Rowell, N. R., Aetiology of certain connective tissue diseases. Clin Exp Immunol 1967, 2, Suppl:813-25.
63. Raychaudhuri, S.; Sandor, C.; Stahl, E. A.; Freudenberg, J.; Lee, H. S.; Jia, X.; Alfredsson, L.; Padyukov, L.; Klareskog, L.; Worthington, J.; Siminovitch, K. A.; Bae, S. C.; Plenge, R. M.; Gregersen, P. K.; de Bakker, P. I., Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012, 44, (3), 291-6.
64. Remmers, E. F.; Plenge, R. M.; Lee, A. T.; Graham, R. R.; Hom, G.; Behrens, T. W.; de Bakker, P. I.; Le, J. M.; Lee, H. S.; Batliwalla, F.; Li, W.; Masters, S. L.; Booty, M. G.; Carulli, J. P.; Padyukov, L.; Alfredsson, L.; Klareskog, L.; Chen, W. V.; Amos, C. I.; Criswell, L. A.; Seldin, M. F.; Kastner, D. L.; Gregersen, P. K., STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357, (10), 977-86.
65. Okada, Y.; Terao, C.; Ikari, K.; Kochi, Y.; Ohmura, K.; Suzuki, A.; Kawaguchi, T.; Stahl, E. A.; Kurreeman, F. A.; Nishida, N.; Ohmiya, H.; Myouzen, K.; Takahashi, M.; Sawada, T.; Nishioka, Y.; Yukioka, M.; Matsubara, T.; Wakitani, S.; Teshima, R.; Tohma, S.; Takasugi, K.; Shimada, K.; Murasawa, A.; Honjo, S.; Matsuo, K.; Tanaka, H.; Tajima, K.; Suzuki, T.; Iwamoto, T.; Kawamura, Y.; Tanii, H.; Okazaki, Y.; Sasaki, T.; Gregersen, P. K.; Padyukov, L.; Worthington, J.; Siminovitch, K. A.; Lathrop, M.; Taniguchi, A.; Takahashi, A.; Tokunaga, K.; Kubo, M.; Nakamura, Y.; Kamatani, N.; Mimori, T.; Plenge, R. M.; Yamanaka, H.; Momohara, S.; Yamada, R.; Matsuda, F.; Yamamoto, K., Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet 2012, 44, (5), 511-6.
66. Gregersen, P. K.; Amos, C. I.; Lee, A. T.; Lu, Y.; Remmers, E. F.; Kastner, D. L.; Seldin, M. F.; Criswell, L. A.; Plenge, R. M.; Holers, V. M.; Mikuls, T. R.; Sokka, T.; Moreland, L. W.; Bridges, S. L., Jr.; Xie, G.; Begovich, A. B.; Siminovitch, K. A., REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009, 41, (7), 820-3.
67. Raychaudhuri, S.; Remmers, E. F.; Lee, A. T.; Hackett, R.; Guiducci, C.; Burtt, N. P.; Gianniny, L.; Korman, B. D.; Padyukov, L.; Kurreeman, F. A.; Chang, M.; Catanese, J. J.; Ding, B.; Wong, S.; van der Helm-van Mil, A. H.; Neale, B. M.; Coblyn, J.; Cui, J.; Tak, P. P.; Wolbink, G. J.; Crusius, J. B.; van der Horst-Bruinsma, I. E.; Criswell, L. A.; Amos, C. I.; Seldin, M. F.; Kastner, D. L.; Ardlie, K. G.; Alfredsson, L.; Costenbader, K. H.; Altshuler, D.; Huizinga, T. W.; Shadick, N. A.; Weinblatt, M. E.; de Vries, N.; Worthington, J.; Seielstad, M.; Toes, R. E.; Karlson, E. W.; Begovich, A. B.; Klareskog, L.; Gregersen, P. K.; Daly, M. J.; Plenge, R. M., Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008, 40, (10), 1216-23.
68. Evans, W. E.; McLeod, H. L., Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med 2003, 348, (6), 538-49.
69. Mallal, S.; Phillips, E.; Carosi, G.; Molina, J. M.; Workman, C.; Tomazic, J.; Jagel-Guedes, E.; Rugina, S.; Kozyrev, O.; Cid, J. F.; Hay, P.; Nolan, D.; Hughes, S.; Hughes, A.; Ryan, S.; Fitch, N.; Thorborn, D.; Benbow, A., HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008, 358, (6), 568-79.
70. Lipsky, P. E.; van der Heijde, D. M.; St Clair, E. W.; Furst, D. E.; Breedveld, F. C.; Kalden, J. R.; Smolen, J. S.; Weisman, M.; Emery, P.; Feldmann, M.; Harriman, G. R.; Maini, R. N., Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000, 343, (22), 1594-602.
71. Smolen, J. S.; Aletaha, D.; Koeller, M.; Weisman, M. H.; Emery, P., New therapies for treatment of rheumatoid arthritis. Lancet 2007, 370, (9602), 1861-74.
72. Genovese, M. C.; Becker, J.-C.; Schiff, M.; Luggen, M.; Sherrer, Y.; Kremer, J.; Birbara, C.; Box, J.; Natarajan, K.; Nuamah, I.; Li, T.; Aranda, R.; Hagerty, D. T.; Dougados, M., Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition. New England Journal of Medicine 2005, 353, (11), 1114-1123.
73. Emery, P.; Keystone, E.; Tony, H. P.; Cantagrel, A.; van Vollenhoven, R.; Sanchez, A.; Alecock, E.; Lee, J.; Kremer, J., IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 2008, 67, (11), 1516-23.
74. Marsal, S.; Julia, A., Rheumatoid arthritis pharmacogenomics. Pharmacogenomics 2010, 11, (5), 617-9.
75. Liu, C.; Batliwalla, F.; Li, W.; Lee, A.; Roubenoff, R.; Beckman, E.; Khalili, H.; Damle, A.; Kern, M.; Furie, R.; Dupuis, J.; Plenge, R. M.; Coenen, M. J.; Behrens, T. W.; Carulli, J. P.; Gregersen, P. K., Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol Med 2008, 14, (9-10), 575-81.
76. Plant, D.; Bowes, J.; Potter, C.; Hyrich, K. L.; Morgan, A. W.; Wilson, A. G.; Isaacs, J. D.; Barton, A., Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum 2011, 63, (3), 645-53.
77. Krintel, S. B.; Palermo, G.; Johansen, J. S.; Germer, S.; Essioux, L.; Benayed, R.; Badi, L.; Ostergaard, M.; Hetland, M. L., Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFalpha inhibitors in patients with rheumatoid arthritis. Pharmacogenet Genomics 2012, 22, (8), 577-89.
78. Barsh, G. S.; Copenhaver, G. P.; Gibson, G.; Williams, S. M., Guidelines for genome-wide association studies. PLoS Genet 2012, 8, (7), e1002812.
79. Umicevic Mirkov, M.; Cui, J.; Vermeulen, S. H.; Stahl, E. A.; Toonen, E. J.; Makkinje, R. R.; Lee, A. T.; Huizinga, T. W.; Allaart, R.; Barton, A.; Mariette, X.; Miceli, C. R.; Criswell, L. A.; Tak, P. P.; de Vries, N.; Saevarsdottir, S.; Padyukov, L.; Bridges, S. L.; van Schaardenburg, D. J.; Jansen, T. L.; Dutmer, E. A.; van de Laar, M. A.; Barrera, P.; Radstake, T. R.; van Riel, P. L.; Scheffer, H.; Franke, B.; Brunner, H. G.; Plenge, R. M.; Gregersen, P. K.; Guchelaar, H. J.; Coenen, M. J., Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Ann Rheum Dis 2012.
80. Wang, J.; Bansal, A. T.; Martin, M.; Germer, S.; Benayed, R.; Essioux, L.; Lee, J. S.; Begovich, A.; Hemmings, A.; Kenwright, A.; Taylor, K. E.; Upmanyu, R.; Cutler, P.; Harari, O.; Marchini, J.; Criswell, L. A.; Platt, A., Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis. Pharmacogenomics J 2012.
81. Knevel, R.; Kwok, K.; de Rooy, D.; Posthumus, M.; Huizinga, T.; Brouwer, E.; van der Helm-van Mil, A., Evaluating joint destruction in rheumatoid arthritis: is it necessary to radiograph both hands and feet? Ann Rheum Dis 2013, 72, (3), 345-9.
82. van der Heijde, D., How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000, 27, (1), 261-3.
83. Pincus, T.; Larsen, A.; Brooks, R. H.; Kaye, J.; Nance, E. P.; Callahan, L. F., Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker stage, Kaye modified Sharp score, and Larsen score. J Rheumatol 1997, 24, (11), 2106-12.
84. van der Heijde, D. M., Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995, 34 Suppl 2, 74-8.
85. Breedveld, F. C.; Weisman, M. H.; Kavanaugh, A. F.; Cohen, S. B.; Pavelka, K.; van Vollenhoven, R.; Sharp, J.; Perez, J. L.; Spencer-Green, G. T., The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006, 54, (1), 26-37.
86. Berglin, E.; Johansson, T.; Sundin, U.; Jidell, E.; Wadell, G.; Hallmans, G.; Rantapaa-Dahlqvist, S., Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgARF at disease onset. Ann Rheum Dis 2006, 65, (4), 453-8.
87. Gorman, J. D.; Lum, R. F.; Chen, J. J.; Suarez-Almazor, M. E.; Thomson, G.; Criswell, L. A., Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 2004, 50, (2), 400-12.
88. Harre, U.; Georgess, D.; Bang, H.; Bozec, A.; Axmann, R.; Ossipova, E.; Jakobsson, P. J.; Baum, W.; Nimmerjahn, F.; Szarka, E.; Sarmay, G.; Krumbholz, G.; Neumann, E.; Toes, R.; Scherer, H. U.; Catrina, A. I.; Klareskog, L.; Jurdic, P.; Schett, G., Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012, 122, (5), 1791-802.
89. Kurreeman, F. A.; Padyukov, L.; Marques, R. B.; Schrodi, S. J.; Seddighzadeh, M.; Stoeken-Rijsbergen, G.; van der Helm-van Mil, A. H.; Allaart, C. F.; Verduyn, W.; Houwing-Duistermaat, J.; Alfredsson, L.; Begovich, A. B.; Klareskog, L.; Huizinga, T. W.; Toes, R. E., A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007, 4, (9), e278.
90. Plant, D.; Thomson, W.; Lunt, M.; Flynn, E.; Martin, P.; Eyre, S.; Farragher, T.; Bunn, D.; Worthington, J.; Symmons, D.; Barton, A., The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology (Oxford) 2011, 50, (1), 78-84.
91. Viatte, S.; Plant, D.; Lunt, M.; Fu, B.; Flynn, E.; Parker, B. J.; Galloway, J.; Solymossy, C.; Worthington, J.; Symmons, D. P.; Dixey, J. J.; Young, A.; Barton, A., Investigation of Rheumatoid Arthritis Genetic Susceptibility Markers in the Early Rheumatoid Arthritis Study Further Replicates the TRAF1 Association with Radiological Damage. J Rheumatol 2013, 40, (2), 144-56.
92. Momozawa, Y.; Mni, M.; Nakamura, K.; Coppieters, W.; Almer, S.; Amininejad, L.; Cleynen, I.; Colombel, J. F.; de Rijk, P.; Dewit, O.; Finkel, Y.; Gassull, M. A.; Goossens, D.; Laukens, D.; Lemann, M.; Libioulle, C.; O'Morain, C.; Reenaers, C.; Rutgeerts, P.; Tysk, C.; Zelenika, D.; Lathrop, M.; Del-Favero, J.; Hugot, J. P.; de Vos, M.; Franchimont, D.; Vermeire, S.; Louis, E.; Georges, M., Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 2011, 43, (1), 43-7.
93. Rivas, M. A.; Beaudoin, M.; Gardet, A.; Stevens, C.; Sharma, Y.; Zhang, C. K.; Boucher, G.; Ripke, S.; Ellinghaus, D.; Burtt, N.; Fennell, T.; Kirby, A.; Latiano, A.; Goyette, P.; Green, T.; Halfvarson, J.; Haritunians, T.; Korn, J. M.; Kuruvilla, F.; Lagace, C.; Neale, B.; Lo, K. S.; Schumm, P.; Torkvist, L.; Dubinsky, M. C.; Brant, S. R.; Silverberg, M. S.; Duerr, R. H.; Altshuler, D.; Gabriel, S.; Lettre, G.; Franke, A.; D'Amato, M.; McGovern, D. P.; Cho, J. H.; Rioux, J. D.; Xavier, R. J.; Daly, M. J., Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011, 43, (11), 1066-73.
94. Diogo, D.; Kurreeman, F.; Stahl, E. A.; Liao, K. P.; Gupta, N.; Greenberg, J. D.; Rivas, M. A.; Hickey, B.; Flannick, J.; Thomson, B.; Guiducci, C.; Ripke, S.; Adzhubey, I.; Barton, A.; Kremer, J. M.; Alfredsson, L.; Sunyaev, S.; Martin, J.; Zhernakova, A.; Bowes, J.; Eyre, S.; Siminovitch, K. A.; Gregersen, P. K.; Worthington, J.; Klareskog, L.; Padyukov, L.; Raychaudhuri, S.; Plenge, R. M., Rare, Low-Frequency, and Common Variants in the Protein-Coding Sequence of Biological Candidate Genes from GWASs Contribute to Risk of Rheumatoid Arthritis. Am J Hum Genet 2013, 92, (1), 15-27.
95. Hu, X.; Kim, H.; Stahl, E.; Plenge, R.; Daly, M.; Raychaudhuri, S., Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets. Am J Hum Genet 2011, 89, (4), 496-506.
96. Gregersen, P. K., Cell type-specific eQTLs in the human immune system. Nat Genet 2012, 44, (5), 478-80.
97. Liu, Y.; Aryee, M. J.; Padyukov, L.; Fallin, M. D.; Hesselberg, E.; Runarsson, A.; Reinius, L.; Acevedo, N.; Taub, M.; Ronninger, M.; Shchetynsky, K.; Scheynius, A.; Kere, J.; Alfredsson, L.; Klareskog, L.; Ekstrom, T. J.; Feinberg, A. P., Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013, 31, (2), 142-7.
98. Arnett, F. C.; Edworthy, S. M.; Bloch, D. A.; McShane, D. J.; Fries, J. F.; Cooper, N. S.; Healey, L. A.; Kaplan, S. R.; Liang, M. H.; Luthra, H. S.; et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31, (3), 315-24.
99. Aletaha, D.; Neogi, T.; Silman, A. J.; Funovits, J.; Felson, D. T.; Bingham, C. O., 3rd; Birnbaum, N. S.; Burmester, G. R.; Bykerk, V. P.; Cohen, M. D.; Combe, B.; Costenbader, K. H.; Dougados, M.; Emery, P.; Ferraccioli, G.; Hazes, J. M.; Hobbs, K.; Huizinga, T. W.; Kavanaugh, A.; Kay, J.; Kvien, T. K.; Laing, T.; Mease, P.; Menard, H. A.; Moreland, L. W.; Naden, R. L.; Pincus, T.; Smolen, J. S.; Stanislawska-Biernat, E.; Symmons, D.; Tak, P. P.; Upchurch, K. S.; Vencovsky, J.; Wolfe, F.; Hawker, G., 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62, (9), 2569-81.